Metabolomic Alterations Associated with Cause of CKD

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1787-1794. doi: 10.2215/CJN.02560317. Epub 2017 Sep 28.

Abstract

Background and objectives: Causes of CKD differ in prognosis and treatment. Metabolomic indicators of CKD cause may provide clues regarding the different physiologic processes underlying CKD development and progression.

Design, setting, participants & measurements: Metabolites were quantified from serum samples of participants in the Modification of Diet in Renal Disease (MDRD) Study, a randomized controlled trial of dietary protein restriction and BP control, using untargeted reverse phase ultraperformance liquid chromatography tandem mass spectrometry quantification. Known, nondrug metabolites (n=687) were log-transformed and analyzed to discover associations with CKD cause (polycystic kidney disease, glomerular disease, and other cause). Discovery was performed in Study B, a substudy of MDRD with low GFR (n=166), and replication was performed in Study A, a substudy of MDRD with higher GFR (n=423).

Results: Overall in MDRD, average participant age was 51 years and 61% were men. In the discovery study (Study B), 29% of participants had polycystic kidney disease, 28% had glomerular disease, and 43% had CKD of another cause; in the replication study (Study A), the percentages were 28%, 24%, and 48%, respectively. In the discovery analysis, adjusted for demographics, randomization group, body mass index, hypertensive medications, measured GFR, log-transformed proteinuria, and estimated protein intake, seven metabolites (16-hydroxypalmitate, kynurenate, homovanillate sulfate, N2,N2-dimethylguanosine, hippurate, homocitrulline, and 1,5-anhydroglucitol) were associated with CKD cause after correction for multiple comparisons (P<0.0008). Five of these metabolite associations (16-hydroxypalmitate, kynurenate, homovanillate sulfate, N2,N2-dimethylguanosine, and hippurate) were replicated in Study A (P<0.007), with all replicated metabolites exhibiting higher levels in polycystic kidney disease and lower levels in glomerular disease compared with CKD of other causes.

Conclusions: Metabolomic profiling identified several metabolites strongly associated with cause of CKD.

Keywords: Body Mass Index; Chromatography, Liquid; Citrulline; Demography; Diet; Dietary Proteins; Hippurates; Kynurenic Acid; MDRD Study; Male; Metabolomic profiling; Polycystic Kidney Diseases; Prognosis; Random Allocation; Renal Insufficiency, Chronic; Sulfates; Tandem Mass Spectrometry; blood pressure; glomerular filtration rate; homocitrulline; kidney; metabolites; proteinuria.

MeSH terms

  • Adult
  • Citrulline / analogs & derivatives
  • Citrulline / blood
  • Deoxyglucose / blood
  • Female
  • Glomerulonephritis / blood*
  • Glomerulonephritis / complications
  • Guanosine / analogs & derivatives
  • Guanosine / blood
  • Hippurates / blood
  • Homovanillic Acid / blood
  • Humans
  • Kynurenic Acid / blood
  • Male
  • Metabolome / physiology*
  • Middle Aged
  • Palmitic Acids / blood
  • Polycystic Kidney Diseases / blood*
  • Polycystic Kidney Diseases / complications
  • Randomized Controlled Trials as Topic
  • Renal Insufficiency, Chronic / blood*
  • Renal Insufficiency, Chronic / etiology*

Substances

  • Hippurates
  • Palmitic Acids
  • homocitrulline
  • Guanosine
  • N(2),N(2)-dimethylguanosine
  • Citrulline
  • 1,5-anhydroglucitol
  • 16-hydroxypalmitic acid
  • Deoxyglucose
  • Kynurenic Acid
  • hippuric acid
  • Homovanillic Acid